Atlas Trials

Dose Optimization by Pharmacokinetic/Pharmacodynamic of Antibiotics to Improve Clinical Outcome of Carbapenem Resistant Klebsiella Pneumoniae Bloodstream Infections in Critically Ill Patients at Phramongkutklao Hospital

Clinical trial NCT05862402 · UNKNOWN

Trial details

NCT number
NCT05862402
Sponsor
Phramongkutklao College of Medicine and Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Carbapenem Resistant Klebsiella Pneumoniae
Start date
2023-05-07
Primary completion
2024-05-31
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.